Literature DB >> 27037661

Rebound pustular psoriasis after brodalumab discontinuation.

A Khemis1, M Cavalié1, H Montaudié1, J-P Lacour1, T Passeron2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27037661     DOI： 10.1111/bjd.14627

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  Successful Treatment of Recurrent Pustular Psoriasis of Pregnancy with Secukinumab: A Case Report.

Authors:  Na Liu; Lin Zhu; Yuanyuan Cheng; Ning Yu; Xuemei Yi; Yangfeng Ding
Journal:  Acta Derm Venereol       Date:  2020-08-19       Impact factor: 3.875

Review 2.  Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis.

Authors:  Ling-Juan Zhang
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 3.  The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.

Authors:  Lixiang Sun; Wenjie Liu; Ling-Juan Zhang
Journal:  J Immunol Res       Date:  2019-11-14       Impact factor: 4.818

Review 4.  Clinical Course and Characteristics of Generalized Pustular Psoriasis.

Authors:  Siew Eng Choon; Alexander A Navarini; Andreas Pinter
Journal:  Am J Clin Dermatol       Date:  2022-01-21       Impact factor: 7.403
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.